ArticleFrontiers in pharmacology2024

Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL.

Yuxin Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.